PLx Pharma Inc.·4

Jun 16, 2:00 PM ET

PLx Pharma Inc. 4

4 · PLx Pharma Inc. · Filed Jun 16, 2017

Insider Transaction Report

Form 4
Period: 2017-06-14
Valentino Michael J
DirectorExecutive Chairman
Transactions
  • Purchase

    Warrant

    2017-06-14+29,09129,091 total
    Exercise: $7.50From: 2017-12-15Exp: 2027-06-14Common Stock (29,091 underlying)
  • Purchase

    Common Stock

    2017-06-14$6.88/sh+29,091$200,001122,386 total
Footnotes (1)
  • [F1]Issued pursuant to a private placement in connection with the purchase of common stock in a registered direct offering.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT